We systematically described the characteristics of our patient cohort, which included a high prevalence of severe AKI occurring in up to 64% (in the MPO-ANCA subgroup), and revealed newly diagnosed disease in 75% of cases. This evidence concerns the gene MPO and acute kidney injury.